Simultaneous pancreas and kidney transplantation. Issue 1 (February 2015)

• Record Type: Journal Article
• Authors: Redfield, Robert R.; Scalea, Joseph R.; Odorico, Jon S.
• Is Part Of: Current opinion in organ transplantation. Volume 20:Issue 1(2015:Feb.)
• Publication Date: 2015-02
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Immunosuppression -- Periodicals; Transplantation immunology -- Periodicals; 617.954
• DOI: 10.1097/MOT.0000000000000146
• Languages: English
• ISSNs: 1087-2418

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Purpose of review</title> <p>Important trends are being observed in pancreas transplantation in the USA. We will describe recent trends in simultaneous pancreas kidney (SPK) transplantation related to immunosuppression, treatment of rejection, and transplantation for patients of advanced age and C-peptide positive diabetes.</p> </sec> <sec> <title>Recent findings</title> <p>Rates of pancreas transplantation have declined, despite improved pancreatic graft outcomes. Regarding immunosuppression, trends in SPK transplantation include T-cell depletion induction therapy, waning mammalian target of rapamycin inhibitor use and steroid use in greater than 50% of pancreas transplant recipients with few patients undergoing late steroid weaning. Rejection of the pancreas may be discordant with the kidney after SPK and there is a greater appreciation of antibody-mediated rejection of the pancreas allograft. De-novo donor-specific antibody without graft dysfunction remains an active area of study, and the treatment for this condition is unclear. SPKs are being performed with greater frequency in type 2 diabetes mellitus patients and in patients of advanced age, with exemplary results.</p> </sec> <sec> <title>Summary</title> <p>The current state of the art in SPK transplantation is yielding superb and improving results.</p> </sec> </abstract>